These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19118554)

  • 1. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.
    Moritoki Y; Zhang W; Tsuneyama K; Yoshida K; Wakabayashi K; Yang GX; Bowlus C; Ridgway WM; Ueno Y; Ansari AA; Coppel RL; Mackay IR; Flavell RA; Gershwin ME; Lian ZX
    Gastroenterology; 2009 Mar; 136(3):1037-47. PubMed ID: 19118554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
    Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
    J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
    Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
    Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
    Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis.
    Zhang W; Moritoki Y; Tsuneyama K; Yang GX; Ilan Y; Lian ZX; Gershwin ME
    Clin Exp Immunol; 2009 Sep; 157(3):359-64. PubMed ID: 19664143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
    Moritoki Y; Lian ZX; Lindor K; Tuscano J; Tsuneyama K; Zhang W; Ueno Y; Dunn R; Kehry M; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2009 Dec; 50(6):1893-903. PubMed ID: 19877182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
    Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
    Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.
    Moritoki Y; Tsuneyama K; Nakamura Y; Kikuchi K; Shiota A; Ohsugi Y; Lian ZX; Zhang W; Yang GX; Ueki S; Takeda M; Omokawa A; Saga T; Saga A; Watanabe D; Miura M; Ueno Y; Leung PSC; Tanaka A; Gershwin ME; Hirokawa M
    Front Immunol; 2018; 9():2534. PubMed ID: 30450101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.
    Oertelt S; Lian ZX; Cheng CM; Chuang YH; Padgett KA; He XS; Ridgway WM; Ansari AA; Coppel RL; Li MO; Flavell RA; Kronenberg M; Mackay IR; Gershwin ME
    J Immunol; 2006 Aug; 177(3):1655-60. PubMed ID: 16849474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.
    Kennedy L; Francis H; Invernizzi P; Venter J; Wu N; Carbone M; Gershwin ME; Bernuzzi F; Franchitto A; Alvaro D; Marzioni M; Onori P; Gaudio E; Sybenga A; Fabris L; Meng F; Glaser S; Alpini G
    FASEB J; 2019 Sep; 33(9):10269-10279. PubMed ID: 31251081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.
    Yang GX; Sun Y; Tsuneyama K; Zhang W; Leung PS; He XS; Ansari AA; Bowlus C; Ridgway WM; Gershwin ME
    Clin Exp Immunol; 2016 Aug; 185(2):154-64. PubMed ID: 27148790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4
    Zhao ZB; Lu FT; Ma HD; Wang YH; Yang W; Long J; Miao Q; Zhang W; Tian Z; Ridgway WM; Cao J; Gershwin ME; Lian ZX
    Cell Mol Immunol; 2020 Feb; 17(2):178-189. PubMed ID: 30874628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.
    Yang JB; Wang YH; Yang W; Lu FT; Ma HD; Zhao ZB; Jia YJ; Tang W; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
    J Autoimmun; 2016 Jan; 66():108-17. PubMed ID: 26432598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
    Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
    Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
    J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
    Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
    Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
    Papadakis KA; Krempski J; Reiter J; Svingen P; Xiong Y; Sarmento OF; Huseby A; Johnson AJ; Lomberk GA; Urrutia RA; Faubion WA
    Am J Physiol Cell Physiol; 2015 Mar; 308(5):C362-71. PubMed ID: 25472963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
    Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
    J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent.
    Yang CY; Leung PS; Yang GX; Kenny TP; Zhang W; Coppel R; Norman GL; Ansari AA; Mackay IR; Worman HJ; Gershwin ME
    Clin Exp Immunol; 2012 Jun; 168(3):261-7. PubMed ID: 22519587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.